ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, W. H.
Right arrow Articles by Huggins, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, W. H., Jr
Right arrow Articles by Huggins, M. P.

The Annals of Thoracic Surgery, Vol 19, 529-536, Copyright © 1975 by The Society of Thoracic Surgeons


ARTICLES

Clinical evaluation of priming solutions for pump oxygenator perfusion

WH Lee Jr, JW Rubin and MP Huggins

Various hemodilution agents are now used routinely to prime heart-lung machines for cardiac operations. Hemodilution has resulted in considerable conservation of blood as well as diminution of plasma and corpuscle damage by decreasing the concentration of these elements in blood during extracorporeal circulation. Controversy has existed regarding the relative efficacy of various hemodilution solutions. This study covers 68 patients, divided into three groups, for whom hemodilution was done as follows: (1) the pump was primed with a 5% dextrose solution containing no colloid; (2) Ringer's lactate solution containing approximately 1% low-molecular-weight dextran was used; and (3) a new plasma expander, hydroxyethyl starch, was used as the colloid component of an electrolyte solution. Evaluations and comparisons were carried out for flow rates, blood pressure, urine volume, hematocrit, BUN, blood loss, clotting factors, and the patient's clinical course with regard to pulmonary and neurological complications. We conclude that a colloid is beneficial, especially with longer perfusions.


This article has been cited by other articles:


Home page
PerfusionHome page
I. Tigchelaar, R. C. G. Huet, P. W Boonstra, and W. van Oeveren
Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients
Perfusion, September 1, 1998; 13(5): 297 - 303.
[Abstract] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
A. Gurbuz, T. Berki, E. Akinci, T. Kocak, and C. Yakut
Hydroxyethyl Starch (HES) as a Priming Solution in Cardiopulmonary Bypass
Vascular and Endovascular Surgery, May 1, 1991; 25(4): 308 - 314.
[Abstract] [PDF]


Home page
PerfusionHome page
L. B. McGrath, L. Gonzalez-Lavin, and M. J. Neary
Comparison of dextran 40 with albumin and Ringer's lactate as components of perfusion prime for cardiopulmonary bypass in patients undergoing myocardial revascularization
Perfusion, January 1, 1989; 4(1): 41 - 49.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1975 by The Society of Thoracic Surgeons.